Time course of Hb level, sEpo, and circulating transferrin receptor in 20 patients undergoing BMT. Data are mean values ± 1 SD. Observed values before myeloablative therapy and those on day 0 are shown. Predicted sEpo values were calculated on the basis of the patient's Hct using the equation derived from regression analysis as previously described.4